Welltower (NYSE:WELL – Free Report) had its price target hoisted by Bank of America from $190.00 to $221.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the real estate investment trust’s stock.
Other analysts have also issued research reports about the company. Jefferies Financial Group raised Welltower from a “hold” rating to a “buy” rating and increased their price objective for the company from $132.00 to $147.00 in a research note on Thursday, January 2nd. Raymond James raised their price objective on Welltower from $145.00 to $155.00 and gave the stock a “strong-buy” rating in a report on Monday, December 16th. Wells Fargo & Company restated an “equal weight” rating and issued a $135.00 price objective (up from $134.00) on shares of Welltower in a report on Tuesday, October 1st. Scotiabank raised their price objective on Welltower from $133.00 to $142.00 and gave the stock a “sector outperform” rating in a report on Monday, November 25th. Finally, Mizuho raised their price objective on Welltower from $136.00 to $141.00 and gave the stock an “outperform” rating in a report on Thursday, December 5th. Five analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $134.81.
View Our Latest Analysis on WELL
Welltower Stock Up 3.4 %
Welltower (NYSE:WELL – Get Free Report) last posted its quarterly earnings data on Monday, October 28th. The real estate investment trust reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.31). The company had revenue of $2.06 billion for the quarter, compared to analyst estimates of $1.95 billion. Welltower had a net margin of 12.22% and a return on equity of 3.20%. The firm’s revenue was up 23.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.92 EPS. As a group, equities research analysts anticipate that Welltower will post 4.3 EPS for the current fiscal year.
Institutional Investors Weigh In On Welltower
A number of hedge funds have recently bought and sold shares of the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Welltower by 638.0% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,920,426 shares of the real estate investment trust’s stock worth $886,022,000 after purchasing an additional 5,982,711 shares during the last quarter. FMR LLC boosted its position in Welltower by 38.1% during the 3rd quarter. FMR LLC now owns 14,428,564 shares of the real estate investment trust’s stock worth $1,847,289,000 after acquiring an additional 3,977,845 shares during the period. Duff & Phelps Investment Management Co. acquired a new stake in shares of Welltower in the second quarter valued at $254,977,000. Wellington Management Group LLP lifted its holdings in shares of Welltower by 10.6% in the third quarter. Wellington Management Group LLP now owns 18,685,844 shares of the real estate investment trust’s stock valued at $2,392,349,000 after buying an additional 1,797,330 shares during the period. Finally, Barclays PLC lifted its holdings in shares of Welltower by 29.2% in the third quarter. Barclays PLC now owns 1,684,446 shares of the real estate investment trust’s stock valued at $215,659,000 after buying an additional 380,888 shares during the period. Institutional investors and hedge funds own 94.80% of the company’s stock.
Welltower Company Profile
Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.
See Also
- Five stocks we like better than Welltower
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- MP Materials: Rare Earth Elements Powering the EV Boom
- What is a support level?
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- The Role Economic Reports Play in a Successful Investment Strategy
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.